19972019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.

  • 6 Similar Profiles
Immunotherapy Medicine & Life Sciences
T-Lymphocytes Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Cancer Vaccines Medicine & Life Sciences
Interleukin-2 Medicine & Life Sciences
Glioma Medicine & Life Sciences
Osteosarcoma Medicine & Life Sciences
Missense Mutation Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1997 2019

6 Citations (Scopus)

Identification of candidate neoantigens produced by fusion transcripts in human osteosarcomas

Rathe, S., Popescu, F. E., Johnson, J. E., Watson, A. L., Marko, T. A., Moriarity, B. S., Ohlfest, J. R. & Largaespada, D. A., Dec 1 2019, In : Scientific reports. 9, 1, 358.

Research output: Contribution to journalArticle

Osteosarcoma
RNA Sequence Analysis
Gene Fusion
Immunotherapy
Canidae
2 Citations (Scopus)

MMuFLR: Missense mutation and frameshift location reporter

Rathe, S., Johnson, J. E., Silverstein, K. A., Erdmann, J. J., Watson, A. L., Popescu, F. E., Ohlfest, J. R. & Largaespada, D. A., Sep 15 2013, In : Bioinformatics. 29, 18, p. 2353-2354 2 p.

Research output: Contribution to journalArticle

Missense Mutation
Mutation
Proteins
Frameshift Mutation
Cancer
23 Citations (Scopus)

An in vivo immunotherapy screen of costimulatory molecules identifies Fc-OX40L as a potent reagent for the treatment of established murine gliomas

Murphy, K. A., Lechner, M. G., Popescu, F. E., Bedi, J., Decker, S. A., Hu, P., Erickson, J. R., O'Sullivan, G., Swier, L., Salazar, A. M., Olin, M. R., Epstein, A. L. & Ohlfest, J. R., Sep 1 2012, In : Clinical Cancer Research. 18, 17, p. 4657-4668 12 p.

Research output: Contribution to journalArticle

Glioma
Immunotherapy
temozolomide
Cancer Vaccines
Vaccines
35 Citations (Scopus)

Enhancement of T-cell-mediated antitumor response: Angiostatic adjuvant to immunotherapy against cancer

Dings, R. P. M., Vang, K. B., Castermans, K., Popescu, F. E., Zhang, Y., Oude Egbrink, M. G. A., Mescher, M. F., Farrar, M. A., Griffioen, A. W. & Mayo, K. H., May 15 2011, In : Clinical Cancer Research. 17, 10, p. 3134-3145 12 p.

Research output: Contribution to journalArticle

Immunotherapy
T-Lymphocytes
Angiogenesis Inhibitors
Neoplasms
Tumor Microenvironment
21 Citations (Scopus)

Superior efficacy of tumor cell vaccines grown in physiologic oxygen

Olin, M. R., Andersen, B. M., Zellmer, D. M., Grogan, P. T., Popescu, F. E., Xiong, Z., Forster, C. L., Seiler, C., SantaCruz, K. S., Chen, W., Blazar, B. R. & Ohlfest, J. R., Oct 1 2010, In : Clinical Cancer Research. 16, 19, p. 4800-4808 9 p.

Research output: Contribution to journalArticle

Cancer Vaccines
Oxygen
Neoplasms
Antigens
Vaccines